SEC Form 4 · accession 0001093557-15-000042
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Robert Pacelli
Officer — EVP, Strategy & Corp. Dev.
Period of report
Feb 23, 2015
Accepted (ET)
Feb 25, 2015 · 6:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 23, 2015 | M | 14,000 | $7.79 | A | 242,866 | D | |
| Common StockF1,F2,F3 | Feb 23, 2015 | S | 14,000 | $63.4302 | D | 228,866 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $7.79 | Feb 23, 2015 | M | 14,000 | D | Aug 2, 2008 | Aug 2, 2017 | Common Stock | 14,000 | 60,508 | D |
Explanation of responses
- F1On December 11, 2014 Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- F2This transaction was executed in multiple trades at prices ranging from $62.82 to $64.32. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- F3Included in this number are 118,748 unvested restricted stock units, 71,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017, 35,811 of which were granted on March 11, 2013 and shall vest through March 11, 2016, and 11,937 of which were granted on March 8, 2012 and shall vest through March 8, 2015.